Processa Pharmaceuticals, Inc. Increase (Decrease) in Inventories and Other Operating Assets
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Inventories and Other Operating Assets of -$38.96 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2017-09-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventoriesAndOtherOperatingAssets · last filed 2017-09-08
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories and other operating assets for the quarter ending 2015-09-30 was $85.48K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories and other operating assets for the quarter ending 2015-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories and other operating assets for the quarter ending 2015-03-31 was -$124.45K.
| Period end | Increase (Decrease) in Inventories and Other Operating Assets 3 month | Increase (Decrease) in Inventories and Other Operating Assets 6 month | Increase (Decrease) in Inventories and Other Operating Assets 9 month |
|---|---|---|---|
| 2015-09-30 | $85.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $85.48K derived: sum of 2 quarters · filed 2017-09-08 | -$38.96K 10-Q · filed 2017-09-08 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$124.45K 10-Q · filed 2017-08-30 | |
| 2015-03-31 | -$124.45K 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |